Effects of Antimicrobial Agents on Renal Function in Patients Administered Vancomycin Hydrochloride

T. Toyoguchi, M. Ebihara, F. Ojima, J. Hosoya, Y. Nakagawa
{"title":"Effects of Antimicrobial Agents on Renal Function in Patients Administered Vancomycin Hydrochloride","authors":"T. Toyoguchi, M. Ebihara, F. Ojima, J. Hosoya, Y. Nakagawa","doi":"10.5649/JJPHCS1975.25.608","DOIUrl":null,"url":null,"abstract":"Abstract-Vancomycin hydrochloride (VCM) has a potent bactericidal activity against Gram positive bacteria, especially, Methicillin-resistant Staphylococcus aureus (MRSA). In the clinical situation, patients infected with not only with MRSA, but also with Gram negative bacterium or fungi are encountered. Because VCM has an adverse reaction of nephrotoxicity, we examined the nephrotoxicity and drug interactions of VCM and some antibiotics and antifungus agents in rabbits. We have already reported on the attenuation of nephrotoxicity by VCM with imipenem/cilastatin sodium, flomoxef sodium, fosfomycin sodium or minocycline hydrochloride, but no attenuation with ceftazidime, cefpimizole sodium or fluconazol. In this study, we investigated the renal function and VCM clearance in MRSA-infected patients, and compared our findings with those in the patients coadministered antimicrobial agents which decreased the nephrotoxicity of VCM in rabbits (decreasing group, n=23) and the patients coadministered the drugs which didn't decrease the nephrotoxicity in rabbits or administered VCM alone (non-decreasing group, n=22). No significant differences were observed regarding age, serum creatinine, BUN, serum potassium, total protein, albumin, WBC and CRP at the starting time of VCM-treatment, VCM doses, period of VCM treatment, and serum VCM concentrations (peak, trough) between the decreasing group and the non-decreasing group. However, the serum creatinine levels in the nondecreasing group were significantly higher than those of the decreasing group at 2 weeks after the VCM theatment. In addition, the serum creatinine levels at the end of the VCM treatment in the non-decreasing group were higher than those of the dereasing group.However, no significant differences were observed in the VCM clearance and BUN between the decreasing group and the non-decreasing group, even though the serum creatinine in the nondecreasing group significantly increased. The high ratio of cancer in our patients (decreasing group n=12, non-decreasing group n=15) may have influenced our resuls. Further investigations are needed to estimate whether or not antimicrobial agents may influence the renal functions in VCM administered patients.","PeriodicalId":17399,"journal":{"name":"Journal of the Nippon Hospital Pharmacists Association","volume":"29 1","pages":"608-613"},"PeriodicalIF":0.0000,"publicationDate":"1999-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Nippon Hospital Pharmacists Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/JJPHCS1975.25.608","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract-Vancomycin hydrochloride (VCM) has a potent bactericidal activity against Gram positive bacteria, especially, Methicillin-resistant Staphylococcus aureus (MRSA). In the clinical situation, patients infected with not only with MRSA, but also with Gram negative bacterium or fungi are encountered. Because VCM has an adverse reaction of nephrotoxicity, we examined the nephrotoxicity and drug interactions of VCM and some antibiotics and antifungus agents in rabbits. We have already reported on the attenuation of nephrotoxicity by VCM with imipenem/cilastatin sodium, flomoxef sodium, fosfomycin sodium or minocycline hydrochloride, but no attenuation with ceftazidime, cefpimizole sodium or fluconazol. In this study, we investigated the renal function and VCM clearance in MRSA-infected patients, and compared our findings with those in the patients coadministered antimicrobial agents which decreased the nephrotoxicity of VCM in rabbits (decreasing group, n=23) and the patients coadministered the drugs which didn't decrease the nephrotoxicity in rabbits or administered VCM alone (non-decreasing group, n=22). No significant differences were observed regarding age, serum creatinine, BUN, serum potassium, total protein, albumin, WBC and CRP at the starting time of VCM-treatment, VCM doses, period of VCM treatment, and serum VCM concentrations (peak, trough) between the decreasing group and the non-decreasing group. However, the serum creatinine levels in the nondecreasing group were significantly higher than those of the decreasing group at 2 weeks after the VCM theatment. In addition, the serum creatinine levels at the end of the VCM treatment in the non-decreasing group were higher than those of the dereasing group.However, no significant differences were observed in the VCM clearance and BUN between the decreasing group and the non-decreasing group, even though the serum creatinine in the nondecreasing group significantly increased. The high ratio of cancer in our patients (decreasing group n=12, non-decreasing group n=15) may have influenced our resuls. Further investigations are needed to estimate whether or not antimicrobial agents may influence the renal functions in VCM administered patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗菌药物对盐酸万古霉素患者肾功能的影响
摘要盐酸万古霉素(VCM)对革兰氏阳性菌,尤其是耐甲氧西林金黄色葡萄球菌(MRSA)具有较强的杀菌活性。在临床情况中,患者感染的不仅仅是MRSA,还有革兰氏阴性菌或真菌。由于VCM具有肾毒性的不良反应,我们研究了VCM与一些抗生素和抗真菌药物的肾毒性和药物相互作用。我们已经报道了亚胺培南/西司他汀钠、氟莫昔钠、磷霉素钠或盐酸米诺环素对VCM肾毒性的衰减,但头孢他啶、头孢吡唑钠或氟康唑对VCM肾毒性没有衰减。在本研究中,我们对mrsa感染患者的肾功能和VCM清除率进行了研究,并将我们的研究结果与共同使用抗菌药物降低兔VCM肾毒性的患者(减少组,n=23)和共同使用不降低兔肾毒性的药物或单独使用VCM的患者(非减少组,n=22)进行了比较。在VCM治疗开始时的年龄、血清肌酐、BUN、血清钾、总蛋白、白蛋白、WBC、CRP、VCM剂量、VCM治疗时间、血清VCM浓度(峰、谷)等方面,下降组与未下降组无显著差异。然而,在VCM治疗后2周,未降低组的血清肌酐水平明显高于降低组。此外,VCM治疗结束时,未降低组血清肌酐水平高于降低组。然而,尽管非下降组的血清肌酐显著升高,但下降组和非下降组的VCM清除率和BUN无显著差异。我们的患者中癌症的高比率(下降组n=12,非下降组n=15)可能影响了我们的结果。需要进一步的研究来评估抗菌药物是否会影响VCM患者的肾功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
An Analysis of Urate-Lowering Drugs Using a Prescription Database 球形吸着炭 (クレメジン原体) の胆汁酸吸着性 癌化学療法時の口内炎に対するプロスタンディン®軟膏・アルロイドG液混合製剤の有効性 Collaboration of Hospital Pharmacists with Pharmaceutical College on Evaluation of Generic Drugs : The Case of Dissolution Test of Sodium Loxoprofen Tablets A Case Report and Evaluation of Pirmenol Toxicity Appeared with Liver Injury
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1